1
Registered trials
0
Recruiting
1
Unique sponsors
1
Unique IMPs
1
Commercial trials
Drug classes (ATC)
N
Neurology/Psychiatry (ATC N)
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (primate)
1 substance
Phase III:
1
Phase III
1 trial-
EndedProthena Biosciences Limited CommercialBIRTAMIMAB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Prothena Biosciences Limited | Commercial | 1 | Phase III | 0 |
New trials by year
2021
1